Skip to content

Assessment of Two Levels of Arterial Pressure on Survival in Patients With Septic Shock

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01149278
Acronym
SEPSISPAM
Enrollment
800
Registered
2010-06-23
Start date
2010-03-31
Completion date
2012-09-30
Last updated
2012-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Pressure, Clinical Trial, Hemodynamics, Mortality, Septic Shock

Brief summary

The ideal mean arterial pressure in patients with septic shock is unknown. The expert's recommandations have stated a target between 65 and 70 mm Hg. However the scientific basis are weak. Indead there are only few prospective studies which addressed this question without clear answer. Therefore we designed a RCT in order to assess the effect on mortality of two levels of mean arterial pressure in patients with septic shock.(800 patients, 30 centres)

Interventions

DRUGmaintain mean arterial pressure between 80-85 mm Hg

protocolized hemodynamic care aiming to maintain mean arterial pressure between 80-85 mm Hg

OTHERmaintain mean arterial pressure between 65-70 mm Hg

protocolized hemodynamic care aiming to maintain mean arterial pressure between 65-70 mm Hg

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with septic shock according criteria of Bone * minimal dose of norepinephrine * Written informed consent obtained from the patient or surrogate

Exclusion criteria

* Age \< 18 years * Pregnancy * Participation in other trials with the same endpoints * moribund * absence of registration in french health care system * patient protected by law

Design outcomes

Primary

MeasureTime frame
mortalityday 28

Secondary

MeasureTime frame
decrease in sequential organ failure assessmentday 1 to day 28
extra renal replacement free daysday 28
decrease in mortality at day 90day 90
amount of fluidsday 1 to end of shock
catecholamines free daysday 1 to day 28
renal functionday 1 to day 28

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026